Archive B Yeager

Guidance on Elements to Consider when Planning for the Integration of Oxytocin into the EPI Cold Chain

The purpose of this document is to provide guidance to national program managers who are considering integrating oxytocin into the EPI cold chain. It is intended for representatives from relevant offices of the Ministry of Health (MoH), such as Pharmacy, Central Medical Stores, and Maternal and Child Health, as well as other policy makers, stakeholders, and … Read more

, , , , , , ,

Guidance for Planning the Introduction of New Reproductive, Maternal, Newborn, and Child Health Medicines and Supplies

The purpose of this document is to provide guidance to program managers in ministries of health at national and sub-national levels as well as personnel in other interested organizations on actions to take and factors to consider when expanding access to essential RMNCH commodities. While this document focuses on RMNCH medicines and supplies, it may be used as a … Read more

, , , , , , , , , ,

Building Systems for Access and Appropriate Use of iCCM Medicines

Briggs J, Yeager B, Diarra S. Building Systems for Access and Appropriate Use of iCCM Medicines. This seminar was presented as part of the 2016 USAID Global Health Mini-University. For more information on the Mini-University, visit www.mini-university.com.

, , , , , ,

Options Analysis for Integration of Oxytocin in the EPI Cold Chain in Mali

The Maternal Health Technical Resource Team (MHTRT) of the UN Commission on Life-Saving Commodities for Women and Children has been exploring strategies to increase access to quality oxytocin, including advocating for the integration of oxytocin in the existing cold chain for the Expanded Programme on Immunization (EPI). Some countries, such as Mali and Ghana, have … Read more

, , , , , , , , , ,

Ensuring Access to and Appropriate Use of Medicines for iCCM: It takes a system

Briggs J, Joshi MP, Yeager B, Diarra S. Ensuring access to and appropriate use of medicines for iCCM: It takes a system. Oral presentation at the 143rd American Public Health Association (APHA) Annual Meeting and Expo, Chicago, IL, USA. November 3, 2015.  

, , , , , , , , ,

Integration of Oxytocin into the Cold Chain of the Expanded Programme on Immunization: Case of Mali

Postpartum hemorrhage (PPH) still remains one of the major causes of maternal mortality, accounting for 35% of all maternal deaths. The World Health Organization (WHO) has recommended oxytocin as the most effective medicine for the prevention and treatment of PPH, particularly for facility-based births. Most countries include oxytocin on their essential medicines lists (EML) as … Read more

, , , , , , , , , ,

Subnational Procurement of Maternal Health Medicines: Results from an Assessment in Bangladesh

SIAPS has developed a methodology and a set of tools to assess the effect of local procurement on the availability of maternal health medicines. SIAPS validated these assessment tools in Bangladesh to allow a broader discussion about potential strategies to improve access to maternal health medicines and to understand how local procurement practices affect access … Read more

, , , , , , , , , ,

Estimation of Unmet Medical Need for Essential Maternal Health Medicines

An alarming number of countries are not on target to meet Millennium Development Goal to reduce maternal mortality despite efforts and investments made at both the global and national levels. Increasing access to and use of essential commodities for maternal health have recently gained attention as key concerns of several international initiatives. The United Nations … Read more

, , , , , , , ,